showed a trendp = 0.089
While pre-procedural INR > 1.5 showed a trend towards increased risk (OR 2.78), it did not reach statistical significance in this model ( p = 0.089).
While pre-procedural INR > 1.5 showed a trend towards increased risk (OR 2.78), it did not reach statistical significance in this model ( p = 0.089).
Age ( p = 0.246), gender ( p = 0.489), BMI ( p = 0.555), obesity ( p = 0.481), smoking history ( p = 0.584), history of DM ( p = 0.606), history of HTN ( p = 0.796), history of CAD ( p = 0.092), history of PVD ( p = 0.573), sheath size ( p = 0.789), type of VCD ( p = 0.106), pre-procedural antithrombotic therapy ( p = 0.442), pre-procedural hemoglobin ≤100 g/L ( p = 0.779), and pre-procedural estimated glomerular filtration rate < 60 mL/min/1.73 m 2 ( p = 0.260) did not reach statistical significance.
Elevated INR > 1.5 (OR 3.55, 95% CI: 0.84–14.92, p = 0.084) and antithrombotic use (OR 2.74, 95% CI: 0.79–9.49, p = 0.112) were not found to be significant but displayed a strong trend towards re-intervention.